irbesartan FDA approval date

The FDA approved irbesartan (Irbesartan Tablets USP) on 30 Sep 1997.

FDA approval date
30 Sep 1997

Drug identity checked against registry records

Also recorded as Irbesartan Tablets USP

Included trials

TrialSponsorPhaseStatusPrimary completion
A Study of the Effect and Safety of Sparsentan in the Treatment of Patients With IgA NephropathyNCT03762850TVTXPhase 3Completed2023-08-07Actual

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
1997-09-30DayirbesartanFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA020757", "applicant_as_listed_by_fda": "SANOFI AVENTIS US", "brand_names": ["AVAPRO"], "active_ingredients": ["IRBESARTAN"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19970930", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026